How to appeal a UnitedHealthcare glp-1 weight-loss drugs denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

UnitedHealthcare-specific note: UHC's parent UnitedHealth Group owns Optum (PBM Optum Rx) and Surest. Surest plans have different cost-sharing rules. State complaints flow to state insurance department + DOL/EBSA for self-funded.

What UnitedHealthcare's policy requires for glp-1 weight-loss drugs

Cited policy: GLP-1 Receptor Agonists for Weight Management

BMI >=30, OR BMI >=27 with at least one weight-related comorbidity (T2DM, hypertension, dyslipidemia, CVD, OSA). 6-month documented diet/exercise program. Step therapy: failed/contraindicated phentermine/topiramate or Contrave trial.

How UnitedHealthcare denies glp-1 weight-loss drugs — and how to counter it

Where UnitedHealthcare pushes back: 1) BMI not documented or below threshold; 2) No documented supervised weight-loss program attempt; 3) Step therapy not completed; 4) Plan excludes weight-loss drugs (employer carve-out).

Counter-arguments that hold up: Cite UnitedHealthcare Bulletin 2023.AM.02 obesity-as-disease. Step-therapy: contraindications to phentermine (CV disease, uncontrolled HTN) or failed Contrave (>=12 weeks). Sub-threshold BMI: ABCD classification (AACE 2023).

What UnitedHealthcare typically denies for glp-1 weight-loss drugs

Across UnitedHealthcare's commercial and Medicare books, denials cluster around a small number of patterns. For glp-1 weight-loss drugs, expect:

• GLP-1 weight-loss exclusion
• Out-of-network reduction citing UCR
• Step therapy on biologics
• Prior auth denied for advanced imaging
• Quantity limits on specialty drugs

Treatments most often denied in this category

These are the glp-1 weight-loss drugs treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Wegovy
• Zepbound
• Mounjaro
• Ozempic
• Saxenda
• PHENTERMINE AND TOPIRAMATE

How to submit the appeal to UnitedHealthcare

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document UnitedHealthcare cited in the denial.
3. File the appeal through UnitedHealthcare's portal (members: https://www.myuhc.com ; providers: https://www.uhcprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See UnitedHealthcare's prior-authorization criteria by drug: UnitedHealthcare PA criteria on ApprovalHelp.